Physicians' Academy for Cardiovascular Education

LDL-c: Done Deal, Next Epigenetics?

Meeting report with video, highlights and slides of a PACE-CME symposium held during ESC 2018 in Munich on the potential role of BET inhibition in the management of CVD and Diabetes - Videos and online CME will be added soon

A clinical view on BET inhibition in targeting residual risk in CVD and diabetes

10' education - Aug. 25, 2018 - ESC 2018 - Munich, Germany - Prof. Kausik Ray, MD - London, UK
BET proteins can stimulate inflammatory processes by regulating genes. Prof. Kausik Ray discusses the role of BET inhibition in reducing CVD risk in patients with diabetes.

BET proteins can stimulate inflammatory processes by regulating genes. Prof. Kausik Ray discusses the role of BET inhibition in reducing CVD risk in patients with diabetes.

Understanding epigenetics: The potential rationale for BET inhibition in management of CVD

10' education - Aug. 25, 2018 - ESC 2018 - Munich, Germany - Jorge Plutzky, MD – Boston, MA, USA
Prof. Jorge Plutzky explains BET inhibition as a novel therapeutic strategy for controlling pathologic cardiovascular responses.

Prof. Jorge Plutzky explains BET inhibition as a novel therapeutic strategy for controlling pathologic cardiovascular responses.

The real residual risk in patients with CVD & diabetes: The promise of epigenetics

10' education - Aug. 25, 2018 - ESC 2018 - Munich, Germany - Prof. Erik Stroes, MD - Amsterdam, The Netherlands
Professor Erik Stroes gives an overview of evidence that inflammation plays a role in CVD and diabetes and considers options to target the hyperactive inflammatory state to lower residual CV risk.

Professor Erik Stroes gives an overview of evidence that inflammation plays a role in CVD and diabetes and considers options to target the hyperactive inflammatory state to lower residual CV risk.

Slides: A clinical view on BET inhibition in targeting residual risk in CVD and diabetes

Presentation Prof. Kausik Ray

Slides (presentation) - Aug. 25, 2018 - Kausik Ray, MD - London, UK
This lecture by prof. Kausik Ray was part of a CME accredited symposium

Slides as educational service to PACE members and meeting participants

Slides: Understanding epigenetics: The potential rationale for BET inhibition in management of CVD

Presentation Prof. Jorge Plutzky

Slides (presentation) - Aug. 25, 2018 - ESC Congress 2018, Munich - Jorge Plutzky, MD - Boston, MA, USA
This lecture by prof. Jorge Plutzky was part of a CME accredited symposium

Slides as educational service to PACE members and meeting participants

Slides: The real residual risk in patients with CVD & diabetes: The promise of epigenetics

Presentation Prof. Erik Stroes

Slides (presentation) - Aug. 25, 2018 - ESC Congress 2018, Munich - Erik Stroes, MD - Amsterdam, The Netherlands
This lecture by prof. Erik Stroes was part of a CME accredited symposium

Slides as educational service to PACE members and meeting participants

LDL-c: Done Deal, Next Epigenetics?
LDL-c: Done Deal, Next Epigenetics?